Home › Trial NCT00679133
Safety Study of Oral MGCD265 Administered With Interruption to Subjects With Advanced Malignancies
- Trial IDNCT00679133
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorMirati Therapeutics Inc.
- Enrollment47
- Start date2008-04
- ConditionsAdvanced Malignancies
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.